Regencell Bioscience Holdings Ltd (RGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2021 | 12-2020 | 06-2020 | 06-2019 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,347 | -334 | -812 | -391 | 112,300 |
| Depreciation Amortization | 27 | 13 | 10 | 0 | 254,800 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | -600 |
| Accounts receivable | N/A | N/A | N/A | N/A | -27,700 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | N/A | 31,100 |
| Other Working Capital | 553 | -53 | 76 | 0 | -46,400 |
| Other Operating Activity | 1 | 0 | -1 | 0 | 86,400 |
| Operating Cash Flow | $-767 | $-374 | $-727 | $-391 | $409,900 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -15 | -118 | 0 | -234,300 |
| Net Acquisitions | 0 | N/A | 0 | 0 | -183,500 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 10,300 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -3,100 |
| Investing Cash Flow | $0 | $-15 | $-118 | $0 | $-410,600 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 1,103,700 |
| Debt Issued | N/A | N/A | N/A | N/A | -23,500 |
| Dividend Paid | 0 | N/A | 0 | 0 | -138,900 |
| Other Financing Activity | 440 | 308 | 988 | 481 | -958,300 |
| Financing Cash Flow | $440 | $308 | $988 | $481 | $-17,000 |
| Beginning Cash Position | 387 | 387 | 243 | 153 | 246,500 |
| End Cash Position | 59 | 306 | 387 | 243 | 228,800 |
| Net Cash Flow | $-328 | $-81 | $144 | $90 | $-17,700 |
| Free Cash Flow | |||||
| Operating Cash Flow | -767 | -374 | -727 | -391 | 409,900 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -250,400 |
| Free Cash Flow | -767 | -374 | -727 | -391 | 159,500 |